X

Clinical Trials

Contact Us

GI Cancer

2018-01 (MBMC only) (breast, lung, and prostate cohorts temporarily closed)

Blood Sample Collection to Evaluate Biomarkers in Subjects with Untreated Solid Tumors


NCI 10231 (MBMC only) Temporarily closed to accrual 8/22/19

NCORP Tissue Procurement Protocol: An NCI Cancer Moonshot Study


URCC 16092

Phase II Study of Low-Dose Ibuprofen for Cognitive Impairment in Cancer Patients Receiving Chemotherapy


S1815

A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers


EAQ162CD (closing May 2 for colon cohort, suspended May 2 for rectal cohort)

Longitudinal Assessment of Financial Burden in Patients with Colon or Rectal Cancer Treated with Curative Intent


EA2165

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer


SWOG 1613 (step 1 temp closed 5/16/19)

A Randomized Phase II Study of Trastuzumab and Pertuzumab (TP) Compared to Cetuximab and Irinotecan (CETIRI) in Advanced/Metastatic Colorectal Cancer (MCRC) with HER-2 Amplification


A021502 (NCT02912559)

Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair


EA2161 (NCT02893930) (temporarily suspended 11/5/18)

A Phase II Study of MLN0128 (TAK-228) in Rapalog-Resistant Advanced Pancreatic Neuroendocrine Tumors (PNET)


NRG GI002 (NCT02921256) – Suspended effective 5/14/19

A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer